| Parameters |
Relapsed |
Total |
p |
|
| Associated malformations |
Yes |
No |
|
|
| Yes |
4 (3.12) |
1 (0.8) |
5 (3.9) |
0.0002 |
| No |
8 (6.25) |
115 (89.8) |
123 (96.1) |
|
| Patients’surgical stories |
|
|
|
|
| Operated directly |
3 (2.34) |
0 |
3 (2.34) |
0.0006 |
| Operated after chemotherapy |
9 (7.03) |
116 (90.63) |
125 (97.66) |
|
| Neoadjuvant chimiotherapy |
|
|
|
|
| Yes |
9 (7.07) |
116 (90.63) |
125 (97.66) |
0.0006 |
| No |
3 (2.34) |
0 |
3 (2.34) |
|
| Number of chemotherapy sessions |
|
|
|
|
| <4 |
7 (5.5) |
5 (3.9) |
12 (9.4) |
0.0000 |
| ≥4 |
5 (3.9) |
111 (86.7) |
116 (90.6) |
|
| Tumor resection |
|
|
|
|
| Completed |
7 (5.5) |
116 (90.63) |
123 (96.1) |
0.0000 |
| Non completed |
5 (3.9) |
0 |
5 (3.9) |
|
| Preoperative tumor rupture |
|
|
|
|
| Yes |
3 (2.34) |
1 (0.8) |
4 (3.12) |
0.0024 |
| No |
9 (7.03) |
115 (89.8) |
124 (96.88) |
|
| Capsular Damage |
|
|
|
|
| Yes |
3 (2.34) |
6 (4.7) |
9 (7.03) |
0.0387 |
| No |
9 (7.03) |
110 (85.9) |
119 (92.97) |
|
| Surgical Stage |
|
|
|
|
| I |
0 |
42 (32.81) |
42 (32.81) |
|
| II |
3 (2.34) |
52 (40.7) |
55 (42.97) |
|
| III |
6 (4.7) |
12 (9.4) |
18 (14.1) |
0.0003 |
| IV |
3 (2.34) |
9 (7.03) |
12 (9.4) |
|
| V |
0 |
1 (0.8) |
1 (0.8) |
|